Market Place
Sourcing Support
All News #Library
Generics
Purdue Pharma partners with MMCAP Infuse to provide low-cost opioid use disorder
08 May 2024 //
PHARMABIZ
Purdue Pharma Enters Agreement to Provide Low-Cost Opioid Use Disorder Treatment
06 May 2024 //
BUSINESSWIRE
FDA Accepts Filing of ANDA & Grants Priority Review for Nalmefene HCI Injection
10 Jun 2021 //
BUSINESSWIRE
US judge paves way for branded & generic opioid makers toface landmark Oct trial
05 Sep 2019 //
ENDPTS
FDA Grants CGT Designation to Purdue`s Investigational Nalmefene HCl Injection
24 Apr 2019 //
BUSINESSWIRE
Family behind Purdue Pharma pushed opioid marketing, MA says
16 Jan 2019 //
REUTERS
Purdue’s secret OxyContin papers should be released, appeals court rules
14 Dec 2018 //
STAT NEWS
Unsealed lawsuit: Opioid firm placed profits over people
06 Jul 2018 //
APNEWS
Nucynta® (tapentadol): Purdue Pharma v. Collegium NF
07 Feb 2018 //
PATENT LITIGATION
Oxycontin® (Oxycodone Hydrochloride): Purdue Pharma v. Ascent Pharmaceuticals,
12 Jan 2018 //
PATENT LITIGATION
Oxycontin® (Oxycodone Hydrochloride): Purdue Pharma L.P V. Kashiv Pharma
03 Jan 2018 //
PATENT LITIGATION
Xtampza® Er (Oxycodone): Purdue Pharma L.P.,The P.F. Laboratories,Rhodes V.Collegium Pharma
21 Apr 2017 //
PATENT LITIGATION
Oxycontin® (Oxycodone Hcl); Purdue Pharma L.PThe P.F. Laboratories & Rhodes V. Abhai And Kvk-Tech
20 Apr 2017 //
PATENT LITIGATION
FDA approves OxyContin for use by children ages 11 to 16
14 Aug 2015 //
FOX NEWS
OxyContin sales put Purdue`s Sackler family on Forbes rich list
06 Jul 2015 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.